Jump To Navigation
LTKE Christmas in July Toy Drive for the Ronald McDonald House of Connecticut is a Success!

LTKE was proud to sponsor a Christmas in July Toy Drive to benefit the Ronald McDonald House of Connecticut. The Toy Drive ran from July 1, 2010 through August 1, 2010. During that period, the firm collected an array of toys and monetary contributions totaling $1,600.00. The donations were presented to the House on August 4, 2010 by several firm members. The toys and donations will go a long way to brighten the days of so many guests at the House. LTKE wishes to thank everyone who contributed to the Toy Drive to make it such a success!

LTKE Christmas in July 350


Front Left to Right:
Joyce Riccitelli, R.N., Nurse Paralegal
Sherley Otero, House guest
Marisa A. Bellair, Esq.

Back Left to Right:
Nicole M. Fournier-Gelston, Esq.
Steven J. Errante, Esq.
Donn A. Swift, Esq.


+ more

TRAIN ACCIDENTS:
If you or someone you know has been injured in a train accident, contact the lawyers at Lynch,Traub, Keefe & Errante for a free consultation. Our experience and proven track record will get you results.

We are currently investigating and evaluating potential cases involving diabetes patients who were treated with Byetta, Januvia and/or Victoza and diagnosed with pancreatic or thyroid cancer. Recent studies have demonstrated an association between these diabetes medications and the development of pancreatic or thyroid cancer. Byetta, Januvia and Victoza are new generation diabetes medications that are currently prescribed in the United States. Byetta and Victoza are injectible medications while Januvia is taken orally. All three medications are referred to as "GLP-1 Agents" – so named for the human hormone which is the target of their action.

If you or someone you know has been injured by Byetta, Januvia and/or Victoza, please contact our law firm for a free consultation.

We are currently investigating and evaluating bleeding injuries associated with the use of Pradaxa®, an anti-clotting medication approved to prevent the formation of blood clots in patients with atrial fibrillation, an abnormal heartbeat. Pradaxa is a medication which, by thinning the blood, can reduce the risk of the formation of blood clots which can result in a stroke. Pradaxa, however, has no effective reversal agent and the danger for those taking Pradaxa is a potentially lethal and irreversible bleeding event.

If you or someone you know has been injured by Pradaxa, please contact our law firm for a free consultation.

+ more

Information Centers
  • Criminal Defense
  • Personal Injury
  • Medical Malpractice
American Association for Justice | Member 2013